Events & Press

Upcoming Events

Advanced Therapies Live 2022

May 24th-25th, 2022

London, England

5th Annual Cell And Gene Therapy Innovation Summit 2022

May 24th-25th, 2022

Berlin, Germany

2022 PDA Advanced Therapy Medicinal Products Conference

June 22nd- 23rd, 2022

Brussels, Belgium

Events

Cell&Gene Meeting on the Med

April 20th - 22nd 2022

Barcelona, Spain

Israeli Society of Gene and Cell

 February 10th 2022

Tel Aviv University

Advanced Therapies Week

January 25th – 28th 2022

Miami Convention Center, Miami Beach Florida

ISBioTech - 10th Spring Meeting Redux

March 15th, 2021

 Online

BioBazz - Experts Weigh in on the Role of Lab Automation and Sensor Technology in Advancing the Cell Therapy and Regenerative Medicine Fields

September 24th, 2020

Online

Latest Advances: OXYGEN AND pH SENSING IN CELL CULTURE

January 12th, 2021

Virtual

Press / Webinars

Point of Care Manufacturing for Next-Generation Advanced Therapies and Solid Tumor Treatments

October 22nd, 2020 | Online

Personalized cancer treatments no longer a dream with new medical tech

March 22th, 2021 | Jpost website

Personalized cancer treatments no longer a dream with new medical tech

January 14th, 2021 |  The Jerusalem Post

ADVA Biotechnology Founder & CEO, Dr. Ohad Karnieli's Interview in the Jerusalem Post Annual Conference 2020

September 24th, 2020 |  Jerusalem Post Annual Conference

Jerusalem Post: ADVA Biotechnology founder explains disruptive medical tech

 September 27th, 2020 |

 Jerusalem Post

Interview with Dr. Ohad Karnieli: Not only for the Rich People: The Company That Will Make Innovative Cancer Treatment Accessible to Everyone

 November 26th, 2020| Online

Expanding access to genetic engineering-based cancer treatments

November 26th, 2020

The Marker: The Inovative and Revolutionary Treatment for Cancer is Accessible to the public

February 13nd, 2020

Dr. Ohad Karnieli, CEO and Founder of Adva Biotechnology in an interview with Keren Ozen at Maariv Business Annual Summit

November 26th, 2020 | YouTube

The Next Generation of Immunotherapy: Custom Cell Engineering

November 4th, 2020 | Globes גלובס